Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Morgan Stanley Maintains Equal-Weight on ViewRay, Lowers Price Target to $4

Morgan Stanley maintains ViewRay (NASDAQ:VRAY) with a Equal-Weight and lowers the price target from $7 to $4.

byBenzinga Newsdesk

May 9, 2022

1 minute read

Morgan Stanley maintains ViewRay (NASDAQ:VRAY) with a Equal-Weight and lowers the price target from $7 to $4.

Recap: Marathon Petroleum Q4 Earnings

By Benzinga Insights

Today, 11:05 PM

Marathon Petroleum (NYSE:MPC) reported its Q4 earnings results on Wednesday, February 2, 2022 at 06:05 AM. Here's what investors need to know about the announcement.

MPC

Why Qualcomm Shares Are Falling

By Adam Eckert

Today, 11:05 PM

Shares of several companies in the broader tech sector, including Qualcomm Inc (NASDAQ: QCOM), are trading lower Thursday afternoon as investors weigh Wednesday's Fed announcements and assess the tapering outlook.

QCOM

Keybanc Maintains Overweight on GitLab, Lowers Price Target to $50

By Benzinga Newsdesk

Today, 11:05 PM

Keybanc analyst Michael Turits maintains GitLab (NASDAQ:GTLB) with a Overweight and lowers the price target from $115 to $50.

GTLB

Josh Brown Says CrowdStrike ‘Would Be $250 Plus’ Under Normal Market Conditions

By Adam Eckert

Today, 11:05 PM

CrowdStrike Holdings Inc (NASDAQ: CRWD) is surging Thursday after the cybersecurity company reported better-than-expected financial results and issued strong guidance, but the stock should be trading even higher, according to Ritholtz Wealth Management's Josh Brown

CRWD

Morgan Stanley Maintains Equal-Weight on ViewRay, Lowers Price Target to $4

Related Posts

Recap: Marathon Petroleum Q4 Earnings

Why Qualcomm Shares Are Falling

Keybanc Maintains Overweight on GitLab, Lowers Price Target to $50

Josh Brown Says CrowdStrike ‘Would Be $250 Plus’ Under Normal Market Conditions